Advertisement
Advertisement

OFIX

OFIX logo

Orthofix Medical Inc. Common Stock (DE)

12.81
USD
Sponsored
+0.11
+0.89%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

12.79

-0.03
-0.21%

OFIX Earnings Reports

Positive Surprise Ratio

OFIX beat 31 of 40 last estimates.

78%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$223.09M
/
-$0.31
Implied change from Q3 25 (Revenue/ EPS)
+8.49%
/
-44.64%
Implied change from Q4 24 (Revenue/ EPS)
+3.45%
/
-1650.00%

Orthofix Medical Inc. Common Stock (DE) earnings per share and revenue

On Nov 04, 2025, OFIX reported earnings of -0.56 USD per share (EPS) for Q3 25, missing the estimate of -0.41 USD, resulting in a -37.42% surprise. Revenue reached 205.63 million, compared to an expected 204.01 million, with a 0.80% difference. The market reacted with a -7.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 223.09 million USD, implying an decrease of -44.64% EPS, and increase of 8.49% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
For Q3 2025, Orthofix Medical Inc. Common Stock (DE) reported EPS of -$0.56, missing estimates by -37.42%, and revenue of $205.63M, 0.8% above expectations.
The stock price moved down -7.41%, changed from $16.06 before the earnings release to $14.87 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 5 analysts, Orthofix Medical Inc. Common Stock (DE) is expected to report EPS of -$0.31 and revenue of $223.09M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement